Search results
Results from the WOW.Com Content Network
The International Society for Pediatric and Adolescent Diabetes is a professional organization located in Berlin, Germany, whose aims are to promote clinical basic science, research, education and advocacy in childhood and adolescent diabetes. ISPAD publishes the journal Pediatric Diabetes. The organization was established in 1974.
Sarilumab, sold under the brand name Kevzara, is a human monoclonal antibody medication against the interleukin-6 receptor. [6] Regeneron Pharmaceuticals and Sanofi developed the drug for the treatment of rheumatoid arthritis (RA), for which it received US FDA approval on 22 May 2017 and European Medicines Agency approval on 23 June 2017.
The Journal of Diabetes is a monthly peer-reviewed medical journal that covers research, therapeutics, and education in the field of diabetes mellitus. It is published by Wiley and is an official journal of the Chinese Society of Endocrinology and endorsed by the Chinese Endocrinologist Association .
For premium support please call: 800-290-4726 more ways to reach us
The Journal of Diabetes Investigation is a bimonthly peer-reviewed medical journal covering the study of diabetes. It was established in 2010 and is published by John Wiley & Sons on behalf of the Asian Association for the Study of Diabetes , of which it is the official journal.
The monthly cost for patients will be 7,504 Japanese yen ($50.15) for a 0.25-milligram starter dose and 42,960 yen for a 2.4 mg dose, Novo said.
The journal was established in 1981 as the Diabetes Bulletin by the founding editor M. M. S. Ahuja. The journal publishes articles on the subject of experimental and clinical aspects of diabetes and its complications. The journal is abstracted and indexed in Academic OneFile, CAB Abstracts, EBSCO Databases, Global Health, Health Reference ...
Current Diabetes Reports is a monthly peer-reviewed medical journal that publishes review articles on all aspects of diabetes. It was established in 2001 and is published by Springer Science+Business Media. The editor-in-chief is Jose C. Florez (Massachusetts General Hospital).